Diao, Guoqing <br/><br/>
Biomarker threshold adaptive designs for survival endpoints.  [electronic resource] 

 -  Journal of biopharmaceutical statistics  2018 
 - 1038-1054 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1520-5711 
<br/><br/><label>Standard No.: </label>10.1080/10543406.2018.1434191  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Algorithms<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Agents, Immunological--therapeutic use<br/>Biomarkers, Tumor--genetics<br/>Biostatistics--methods<br/>Clinical Decision-Making<br/>Clinical Trials, Phase III as Topic--methods<br/>Computer Simulation<br/>Data Interpretation, Statistical<br/>ErbB Receptors--antagonists & inhibitors<br/>Head and Neck Neoplasms--drug therapy<br/>Humans<br/>Models, Statistical<br/>Neoplasms--drug therapy<br/>PTEN Phosphohydrolase--genetics<br/>Panitumumab--therapeutic use<br/>Patient Selection<br/>Precision Medicine--methods<br/>Predictive Value of Tests<br/>Randomized Controlled Trials as Topic--methods<br/>Research Design--statistics & numerical data<br/>Squamous Cell Carcinoma of Head and Neck--drug therapy<br/>Survival Analysis<br/>Time Factors<br/>Treatment Outcome